Francis Ntwali, Quentin Gilliaux, Patrick M. Honoré
{"title":"Nivolumab诱导的细胞因子释放综合征：病例报告和文献综述","authors":"Francis Ntwali, Quentin Gilliaux, Patrick M. Honoré","doi":"10.12659/ajcr.941835","DOIUrl":null,"url":null,"abstract":"infusion of hydrocortisone. Conclusions: The use of ICIs is expanding. Nivolumab-induced CRS is rarely described but can be severe and lead to multiple organ dysfunction; therefore, intensive care practitioners should be informed about this adverse effect. More studies are needed to better understand this condition and establish treatment guidelines.","PeriodicalId":504238,"journal":{"name":"American Journal of Case Reports","volume":"14 6‐7","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Nivolumab-Induced Cytokine Release Syndrome: A Case Report and Literature Review\",\"authors\":\"Francis Ntwali, Quentin Gilliaux, Patrick M. Honoré\",\"doi\":\"10.12659/ajcr.941835\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"infusion of hydrocortisone. Conclusions: The use of ICIs is expanding. Nivolumab-induced CRS is rarely described but can be severe and lead to multiple organ dysfunction; therefore, intensive care practitioners should be informed about this adverse effect. More studies are needed to better understand this condition and establish treatment guidelines.\",\"PeriodicalId\":504238,\"journal\":{\"name\":\"American Journal of Case Reports\",\"volume\":\"14 6‐7\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Case Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12659/ajcr.941835\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12659/ajcr.941835","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Nivolumab-Induced Cytokine Release Syndrome: A Case Report and Literature Review
infusion of hydrocortisone. Conclusions: The use of ICIs is expanding. Nivolumab-induced CRS is rarely described but can be severe and lead to multiple organ dysfunction; therefore, intensive care practitioners should be informed about this adverse effect. More studies are needed to better understand this condition and establish treatment guidelines.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
